Table 3.
Group C (n=6) | Group IR (n=6) | Group IR-A (n=6) | Group IR-I (n=6) | P-value** | |
---|---|---|---|---|---|
PMNL infiltration | 0.00±0.00* | 1.17±0.31 | 0.83±0.31 | 0.00±0.00* | 0.002 |
Edema | 0.00±0.00 | 0.17±0.17 | 0.00±0.00 | 0.00±0.00 | 0.413 |
Myocyte disorganization, degeneration, necrosis | 0.00±0.00 | 0.17±0.17 | 0.00±0.00 | 0.00±0.00 | 0.413 |
Notes:
Significance level with Kruskal–Wallis test, P<0.05.
P<0.05 compared with Group IR. Group C is the Control Group, Group IR is the Ischemia Reperfusion Group, Group IR-A is the Ischemia Reperfusion Group treated with Alprostadil, Group IR-I is the Ischemia Reperfusion Group Treated with Iloprost.
Abbreviation: PMNL, polymorphonuclear leukocyte.